Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-31

Clinical Trial Update: Investigation of Tibolone and Escitalopram in Perimenopausal Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating tibolone in combination with escitalopram for perimenopausal depression was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)
  • Tibolone (tibolone)

Snippet

Sponsor: The Alfred | Conditions: Perimenopausal Depression | Phase 4 | Status: TERMINATED